Financials

News Discussions Technicals Seasonals

ENZY fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Enzymatica AB engages in the research, development, and sale of medical technology products. It offers medical devices in upper respiratory infections and oral health. The company was founded by Ulf Blom, Jorgen Rexo, Ake Larsson, and Staffan Bergqvist in 2007 and is headquartered in Lund, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

ENZY has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company